Advertisement
PODD vs TMDX
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PODD is a Hold and TMDX is a Buy.
Momentum Indicator for PODD turns positive, indicating new upward trend
PODD saw its Momentum Indicator move above the 0 level on November 11, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 90 similar instances where the indicator turned positive. In 65 of the 90 cases, the stock moved higher in the following days. The odds of a move higher are at 72%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.
PODD moved above its 50-day moving average on October 16, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for PODD crossed bullishly above the 50-day moving average on October 23, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 9 of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 64%.
Following a +7.43% 3-day Advance, the price is estimated to grow further. Considering data from situations where PODD advanced for three days, in 208 of 314 cases, the price rose further within the following month. The odds of a continued upward trend are 66%.
The Aroon Indicator entered an Uptrend today. In 104 of 174 cases where PODD Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 60%.
Bearish Trend Analysis
The 10-day RSI Indicator for PODD moved out of overbought territory on November 05, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 24 similar instances where the indicator moved out of overbought territory. In 17 of the 24 cases, the stock moved lower in the following days. This puts the odds of a move lower at 71%.
The Moving Average Convergence Divergence Histogram (MACD) for PODD turned negative on November 10, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In 34 of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at 72%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where PODD declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 71%.
PODD broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron SMR rating for this company is 37 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is 57 (best 1 - 100 worst), indicating steady price growth. PODD’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 77 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (7.145) is normal, around the industry mean (4.142). P/E Ratio (27.334) is within average values for comparable stocks, (3.291). Projected Growth (PEG Ratio) (1.047) is also within normal values, averaging (11.253). Dividend Yield (0.000) settles around the average of (0.011) among similar stocks. P/S Ratio (3.294) is also within normal values, averaging (40.124).
The Tickeron PE Growth Rating for this company is 96 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PODD’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
TMDX's MACD Histogram crosses above signal line
The Moving Average Convergence Divergence (MACD) for TMDX turned positive on November 04, 2026. Looking at past instances where TMDX's MACD turned positive, the stock continued to rise in 43 of 49 cases over the following month. The odds of a continued upward trend are 88%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on November 06, 2026. You may want to consider a long position or call options on TMDX as a result. In 76 of 89 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 85%.
TMDX moved above its 50-day moving average on November 06, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +35.97% 3-day Advance, the price is estimated to grow further. Considering data from situations where TMDX advanced for three days, in 254 of 303 cases, the price rose further within the following month. The odds of a continued upward trend are 84%.
Bearish Trend Analysis
The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where TMDX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 80%.
TMDX broke above its upper Bollinger Band on November 06, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for TMDX entered a downward trend on November 05, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron SMR rating for this company is 28 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is 41 (best 1 - 100 worst), indicating steady price growth. TMDX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 65 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock slightly better than average.
The Tickeron Valuation Rating of 70 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.906) is normal, around the industry mean (4.142). P/E Ratio (19.829) is within average values for comparable stocks, (3.291). Projected Growth (PEG Ratio) (0.709) is also within normal values, averaging (11.253). Dividend Yield (0.000) settles around the average of (0.011) among similar stocks. P/S Ratio (5.033) is also within normal values, averaging (40.124).
The Tickeron PE Growth Rating for this company is 92 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
PODD | TMDX | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 41 | 31 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 77 Overvalued | 70 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | 65 | |
SMR RATING 1..100 | 37 | 28 | |
PRICE GROWTH RATING 1..100 | 57 | 41 | |
P/E GROWTH RATING 1..100 | 96 | 92 | |
SEASONALITY SCORE 1..100 | n/a | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
TMDX's Valuation (70) in the Medical Specialties industry is in the same range as PODD (77). This means that TMDX’s stock grew similarly to PODD’s over the last 12 months.
TMDX's Profit vs Risk Rating (65) in the Medical Specialties industry is somewhat better than the same rating for PODD (100). This means that TMDX’s stock grew somewhat faster than PODD’s over the last 12 months.
TMDX's SMR Rating (28) in the Medical Specialties industry is in the same range as PODD (37). This means that TMDX’s stock grew similarly to PODD’s over the last 12 months.
TMDX's Price Growth Rating (41) in the Medical Specialties industry is in the same range as PODD (57). This means that TMDX’s stock grew similarly to PODD’s over the last 12 months.
TMDX's P/E Growth Rating (92) in the Medical Specialties industry is in the same range as PODD (96). This means that TMDX’s stock grew similarly to PODD’s over the last 12 months.
| PODD | TMDX | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 71% | 1 day ago 79% |
| Stochastic ODDS (%) | 1 day ago 70% | 1 day ago 80% |
| Momentum ODDS (%) | 1 day ago 72% | 1 day ago 85% |
| MACD ODDS (%) | 1 day ago 72% | 1 day ago 88% |
| TrendWeek ODDS (%) | 1 day ago 75% | 1 day ago 85% |
| TrendMonth ODDS (%) | 1 day ago 69% | 1 day ago 85% |
| Advances ODDS (%) | 8 days ago 66% | 3 days ago 84% |
| Declines ODDS (%) | 6 days ago 71% | 15 days ago 80% |
| BollingerBands ODDS (%) | 1 day ago 68% | 1 day ago 85% |
| Aroon ODDS (%) | 1 day ago 60% | 1 day ago 85% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
PODD’s FA Score shows that 0 FA rating(s) are green while TMDX’s FA Score has 1 green FA rating(s).
- PODD’s FA Score: 0 green, 5 red.
- TMDX’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
PODD’s TA Score shows that 6 TA indicator(s) are bullish while TMDX’s TA Score has 4 bullish TA indicator(s).
- PODD’s TA Score: 6 bullish, 4 bearish.
- TMDX’s TA Score: 4 bullish, 5 bearish.
Price Growth
PODD (@Medical/Nursing Services) experienced а -9.08% price change this week, while TMDX (@Medical/Nursing Services) price change was +26.47% for the same time period.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -2.76%. For the same industry, the average monthly price growth was -4.63%, and the average quarterly price growth was -1.72%.
Reported Earning Dates
PODD is expected to report earnings on Feb 25, 2027.
TMDX is expected to report earnings on Mar 02, 2027.
Industries' Descriptions
@Medical/Nursing Services (-2.76% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
Advertisement
PODD and
Correlation & Price change
A.I.dvisor indicates that over the last year, PODD has been loosely correlated with ISRG. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if PODD jumps, then ISRG could also see price increases.
| Ticker / NAME | Correlation To PODD | 1D Price Change % | ||
|---|---|---|---|---|
| PODD | 100% | +1.33% | ||
| ISRG - PODD | 49% Loosely correlated | -0.11% | ||
| DXCM - PODD | 48% Loosely correlated | +0.53% | ||
| MDT - PODD | 44% Loosely correlated | +0.02% | ||
| SYK - PODD | 41% Loosely correlated | -1.70% | ||
| ATEC - PODD | 40% Loosely correlated | +5.00% | ||
More | ||||
TMDX and
Correlation & Price change
A.I.dvisor indicates that over the last year, TMDX has been loosely correlated with ATEC. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if TMDX jumps, then ATEC could also see price increases.
| Ticker / NAME | Correlation To TMDX | 1D Price Change % | ||
|---|---|---|---|---|
| TMDX | 100% | +1.17% | ||
| ATEC - TMDX | 37% Loosely correlated | +5.00% | ||
| RDNT - TMDX | 35% Loosely correlated | +0.18% | ||
| SMTI - TMDX | 34% Loosely correlated | -0.16% | ||
| ALGN - TMDX | 33% Loosely correlated | -1.25% | ||
| PODD - TMDX | 32% Poorly correlated | +1.33% | ||
More | ||||
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| QTOC | 37.15 | 0.74 | +2.02% |
| Innovator Growth Accelerated Plus ETF - October (QTOC) | |||
| ZOCT | 28.24 | 0.09 | +0.32% |
| Innovator 1 Yr October (ZOCT) | |||
| NUDM | 39.66 | 0.02 | +0.05% |
| Nuveen ESG International Developed Markets Equity ETF (NUDM) | |||
| SHAG | 46.61 | -0.03 | -0.07% |
| WisdomTree Yield Enhanced U.S. Short-Term Aggregate Bond Fund (SHAG) | |||
| IEF | 90.94 | -0.07 | -0.08% |
| iShares 7-10 Year Treasury Bond ETF (IEF) | |||